Enzalutamide Before Surgery in Treating Patients With Kidney Cancer

NCT02885649 · clinicaltrials.gov ↗

EARLY_PHASE1

Phase

TERMINATED

Status

3

Enrollment

OTHER

Sponsor class

Stopped Funding unavailable

Conditions

Clear Cell Renal Cell Carcinoma
Stage I Renal Cell Cancer

Interventions

DRUG: Enzalutamide
OTHER: Laboratory Biomarker Analysis
PROCEDURE: Nephrectomy

Sponsor

Rutgers, The State University of New Jersey

Collaborators

[object Object]